LAPTM4B Gene: Lysosomal Protein Transmembrane 4 Beta

A comprehensive resource for LAPTM4B, including genomic data, expression, mutations, and disease associations.

Gene Information Card

Symbol LAPTM4B
Full Name Lysosomal Protein Transmembrane 4 Beta
Gene Type Protein coding
Chromosomal Location 8q22.1
NCBI Gene ID 55353 ncbi.nlm.nih.gov/gene/55353
Ensembl ID ENSG00000104341
UniProt ID Q86VQ1
OMIM ID 613296
HGNC ID 16623
Aliases LAPTM4beta, LAPTM4B-35, LAPTM4B-24

Description

LAPTM4B (Lysosomal Protein Transmembrane 4 Beta) is a protein-coding gene located on chromosome 8q22.1. It encodes a lysosomal transmembrane protein involved in endosomal trafficking, autophagy, and drug resistance. Overexpression of LAPTM4B is associated with various cancers, including breast, liver, and lung cancers, and is linked to poor prognosis and chemoresistance.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer Overexpression promotes cell proliferation, invasion, and resistance to chemotherapy (e.g., anthracyclines). PMID: 20010872, COSMIC
Hepatocellular Carcinoma Upregulation correlates with tumor progression, metastasis, and poor survival. PMID: 17909063, NCBI Gene
Lung Cancer High expression associated with increased tumor growth and resistance to cisplatin. PMID: 23469163, COSMIC
Gastric Cancer LAPTM4B overexpression linked to lymph node metastasis and advanced stage. PMID: 23541959, NCBI Gene

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Breast 8.3 Low
Lung 10.1 Medium
Stomach 9.7 Low
Kidney 7.4 Low
Cell Line Expression
Cell Line nTPM Notes
MCF7 (Breast cancer) 15.2 High expression
HepG2 (Liver cancer) 18.6 High expression
A549 (Lung cancer) 14.0 High expression
HeLa (Cervical cancer) 11.3 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.1% Potential loss of start codon; uncertain significance
c.100C>T (p.Arg34Trp) Missense <0.1% Unknown effect; rare variant
c.200_201insA Frameshift <0.1% Predicted loss of function
c.300G>A (p.Trp100*) Nonsense <0.1% Premature stop; likely loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations (e.g., c.200_201insA, c.300G>A) are predicted to cause loss of function by truncating the protein.

Gain of Function (GOF)

Gene amplification and overexpression are common gain-of-function mechanisms in cancer, but specific point mutations conferring gain-of-function are not well documented.

Dominant Negative (DN)

No dominant negative mutations have been reported for LAPTM4B.

Gene Ontology (GO)

• lysosome (GO:0005764) • integral component of membrane (GO:0016021)
• autophagy (GO:0006914) • response to drug (GO:0042493)
• cell proliferation (GO:0008283)

Pathways

• Autophagy - lysosome pathway
• Endosomal trafficking
• Drug resistance in cancer

Protein Summary

LAPTM4B encodes a 35 kDa lysosomal transmembrane protein (LAPTM4B-35) and a shorter 24 kDa isoform (LAPTM4B-24). The protein localizes to lysosomes and late endosomes, where it regulates vesicle trafficking, autophagy, and lysosomal function. Overexpression in cancer cells enhances lysosomal sequestration of chemotherapeutic drugs, contributing to multidrug resistance. LAPTM4B also interacts with signaling pathways such as PI3K/AKT to promote cell survival and proliferation.

Related Products

Product name Cat.No. Species Gene ID
LAPTM4B Knockout HCT 116 Cell Line EDJ-KQ40591 Human 55353 Details Get a Quote
LAPTM4B Knockout A-549 Cell Line EDJ-KQ40590 Human 55353 Details Get a Quote
LAPTM4B Knockout HeLa Cell Line EDJ-KQ17939 Human 55353 Details Get a Quote
LAPTM4B Knockout HEK293 Cell Line EDJ-KQ12004 Human 55353 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: